发明授权
- 专利标题： Drug combinations for the treatment of duchenne muscular dystrophy
- 专利标题（中）： 药物组合治疗杜氏肌营养不良症
-
申请号： US12600242申请日： 2008-08-01
-
公开(公告)号： US08501713B2公开(公告)日： 2013-08-06
- 发明人: Graham Michael Wynne , Stephen Paul Wren , Peter David Johnson , Paul Damien Price , Olivier De Moor , Gary Nugent , Richard Storer , Richard Joseph Pye , Colin Richard Dorgan
- 申请人： Graham Michael Wynne , Stephen Paul Wren , Peter David Johnson , Paul Damien Price , Olivier De Moor , Gary Nugent , Richard Storer , Richard Joseph Pye , Colin Richard Dorgan
- 申请人地址： GB Abingdon
- 专利权人： Summit Corporation PLC
- 当前专利权人： Summit Corporation PLC
- 当前专利权人地址： GB Abingdon
- 代理机构： Heslin Rothenberg Farley & Mesiti P.C.
- 优先权： GB0715088.1 20070803; GB0807216.7 20080421
- 国际申请： PCT/GB2008/050648 WO 20080801
- 国际公布： WO2009/019504 WO 20090212
- 主分类号： A01N57/00
- IPC分类号： A01N57/00 ; A61K31/675 ; C07F9/28 ; C07D209/48 ; C07D307/00
摘要：
Combinations comprising (or consisting essentially of) one or more compounds of formula (1) with one or more ancillary agents, to processes for preparing the combinations, and to various therapeutic uses of the combinations. Also provided are pharmaceutical compositions containing the combinations as well as a method of treatment of Duchenne muscular dystrophy, Becker muscular dystrophy or cachexia using the combinations.
公开/授权文献
信息查询
